The acute effect of continuous positive airway pressure titration on blood pressure in awake overweight/obese patients with obstructive sleep apnoea

Abstract Objectives: Continuous positive airway pressure (CPAP) improves upper airway obstruction in patients with obstructive sleep apnoea (OSA), who often are overweight-obese. Although it is thought that CPAP improves long-term blood pressure control (BP), the impact of acute and short-term CPAP use on the cardiovascular system in obese patients has not been described in detail. Methods: Obese patients (body mass index, BMI > 25 kg/m2) with OSA were studied awake, supine during incremental CPAP titration (4–20 cmH2O, +2 cmH2O/3 mins). BP was measured continuously with a beat-to-beat BP monitor (Ohmeda 2300, Finapres Medical Systems, Amsterdam/NL), BP variability (BPV) was calculated as the standard deviation of BP at each CPAP level, the 95% confidence interval (95%CI) was calculated and changes in BP and BPV were reported. Results: 15 patients (12 male, 48 ± 10) years, BMI 38.9 ± 5.8 kg/m2) were studied; the baseline BP was 131.0 ± 10.2/85.1 ± 9.1 mmHg. BP and BPV increased linearly with CPAP titration (systolic BP r = 0.960, p < .001; diastolic BP r = 0.961, p < .001; systolic BPV r = 0.662, p = .026; diastolic BPV r = 0.886, p < .001). The systolic BP increased by +17% (+23.15 (7.9, 38.4) mmHg; p = .011) and the diastolic BP by +23% (+18.27 (2.33, 34.21) mmHg; p = .009), when titrating CPAP to 20 cmH2O. Systolic BPV increased by +96% (+5.10 (0.67, 9.53) mmHg; p < .001) and was maximal at 14 cmH2O, and diastolic BPV by +97% (+3.02 (0.26, 5.78) mmHg; p < .001) at 16 cmH2O. Conclusion: Short-term incremental CPAP leads to significant increases in BP and BPV in obese patients with OSA while awake. Careful titration of pressures is required to minimise the risk of nocturnal awakenings while improving BP control.

[1]  S. Bonafini,et al.  Cardiorespiratory interaction with continuous positive airway pressure. , 2018, Journal of thoracic disease.

[2]  A. Simonds,et al.  Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. , 2016, The Lancet. Respiratory medicine.

[3]  Rui Chen,et al.  CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. , 2016, The New England journal of medicine.

[4]  M. Kohler,et al.  Effect of Continuous Positive Airway Pressure on Blood Pressure Variability in Patients With Obstructive Sleep Apnea , 2016, Journal of clinical hypertension.

[5]  C. Jolley,et al.  Continuous Positive Airway Pressure and Breathlessness in Obese Patients with Obstructive Sleep Apnea: A Pilot Study. , 2016, Sleep.

[6]  David Gozal,et al.  The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database , 2016, European Respiratory Journal.

[7]  L. Sharples,et al.  Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea , 2015, Sleep medicine reviews.

[8]  Ian Graham,et al.  EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE , 2005 .

[9]  C. Janson,et al.  The impact of obesity and weight gain on development of sleep problems in a population-based sample. , 2015, Sleep medicine.

[10]  S. Chevret,et al.  Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries , 2015, Intensive Care Medicine.

[11]  J. Steier,et al.  Predicted relative prevalence estimates for obstructive sleep apnoea and the associated healthcare provision across the UK , 2013, Thorax.

[12]  E. Bonanni,et al.  Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors , 2013, Journal of hypertension.

[13]  C. Kosky,et al.  Obesity as an independent predictor of subjective excessive daytime sleepiness. , 2013, Respiratory medicine.

[14]  G. Uwaifo Obesity-Associated Hypertension , 2013 .

[15]  J. Montserrat,et al.  Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. , 2012, American journal of respiratory and critical care medicine.

[16]  Malcolm Kohler,et al.  Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial , 2012, Thorax.

[17]  J. Steier,et al.  Excessive daytime sleepiness in sleep disorders. , 2012, Journal of thoracic disease.

[18]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[19]  J. Montserrat,et al.  Cardiovascular Mortality in Women With Obstructive Sleep Apnea With or Without Continuous Positive Airway Pressure Treatment , 2012, Annals of Internal Medicine.

[20]  Roberto da Silva,et al.  Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors , 2012, Sleep and Breathing.

[21]  E. Moya,et al.  Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia , 2011, European Respiratory Journal.

[22]  R. Nowak,et al.  Noninvasive continuous or intermittent blood pressure and heart rate patient monitoring in the ED. , 2011, The American journal of emergency medicine.

[23]  S. Ancoli-Israel,et al.  Effects of continuous positive airway pressure on fatigue and sleepiness in patients with obstructive sleep apnea: data from a randomized controlled trial. , 2011, Sleep.

[24]  N. Prabhakar,et al.  Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia , 2010, Respiratory Physiology & Neurobiology.

[25]  M. Polkey,et al.  Increased load on the respiratory muscles in obstructive sleep apnea , 2010, Respiratory Physiology & Neurobiology.

[26]  P. Lévy,et al.  Sleep, sleep-disordered breathing and metabolic consequences , 2009, European Respiratory Journal.

[27]  A. Malhotra,et al.  Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. , 2009, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[28]  M. Polkey,et al.  Neural respiratory drive in obesity , 2009, Thorax.

[29]  G. Boysen,et al.  European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.

[30]  J. Floras,et al.  Obstructive sleep apnoea and its cardiovascular consequences , 2009, The Lancet.

[31]  John Moxham,et al.  Diaphragm electromyography using an oesophageal catheter: current concepts. , 2008, Clinical science.

[32]  T. Young,et al.  Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun , 2008, Journal of the American College of Cardiology.

[33]  David Gozal,et al.  Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. , 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[34]  Ronald R Grunstein,et al.  Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. , 2008, Proceedings of the American Thoracic Society.

[35]  W. Elliott Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea , 2008 .

[36]  K. Reynolds,et al.  Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea , 2007, Hypertension.

[37]  Sairam Parthasarathy,et al.  Early CPAP use identifies subsequent adherence to CPAP therapy. , 2007, Sleep.

[38]  W. T. McNicholas,et al.  Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities , 2006, European Respiratory Journal.

[39]  J. Moran,et al.  Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis , 2006, The Lancet.

[40]  R. Mcevoy,et al.  Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis , 2006, Thorax.

[41]  P. Castiglioni,et al.  Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP , 2006, European Respiratory Journal.

[42]  B. Phillips Sleepiness, Sleep-Disordered Breathing, and Accident Risk Factors in Commercial Vehicle Drivers , 2006 .

[43]  Jose M Marin,et al.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study , 2005, The Lancet.

[44]  A. Mark,et al.  Obesity-associated hypertension: new insights into mechanisms. , 2005, Hypertension.

[45]  Anup V. Desai,et al.  Sleepiness, sleep-disordered breathing, and accident risk factors in commercial vehicle drivers. , 2004, American journal of respiratory and critical care medicine.

[46]  T. Kurki,et al.  Noninvasive continuous blood pressure measurement from the finger: Optimal measurement conditions and factors affecting reliability , 2004, Journal of Clinical Monitoring.

[47]  J. Parish,et al.  Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. , 2003, Chest.

[48]  M. Jadoul,et al.  Obstructive sleep apnoea , 2002, The Lancet.

[49]  J. Sorkin,et al.  Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. , 2002, American journal of respiratory and critical care medicine.

[50]  D. Gozal,et al.  Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits , 2002, Journal of sleep research.

[51]  J. Hall,et al.  Obesity hypertension: role of leptin and sympathetic nervous system. , 2001, American journal of hypertension.

[52]  C W Whitney,et al.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. , 2001, American journal of respiratory and critical care medicine.

[53]  E. Fletcher Effect of episodic hypoxia on sympathetic activity and blood pressure. , 2000, Respiration physiology.

[54]  V. Somers,et al.  Obstructive sleep apnea as a cause of neurogenic hypertension , 1999, Current hypertension reports.

[55]  V. Somers,et al.  Sympathetic activity in obese subjects with and without obstructive sleep apnea. , 1998, Circulation.

[56]  K. Wesseling,et al.  Fifteen years experience with finger arterial pressure monitoring: assessment of the technology. , 1998, Cardiovascular research.

[57]  B. Lüderitz,et al.  [Sleep apnea and cardiovascular risk]. , 1995, Zeitschrift fur Kardiologie.

[58]  F. Abboud,et al.  Sympathetic neural mechanisms in obstructive sleep apnea. , 1995, The Journal of clinical investigation.

[59]  G. Mancia,et al.  Sympathetic activation in obese normotensive subjects. , 1995, Hypertension.

[60]  G Parati,et al.  Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings. , 1993, Hypertension.

[61]  F. Abboud,et al.  Sympathetic-nerve activity during sleep in normal subjects. , 1993, The New England journal of medicine.

[62]  J. Fleetham,et al.  The acute effects of continuous positive airway pressure and oxygen administration on blood pressure during obstructive sleep apnea. , 1992, Chest.

[63]  M. Tuck Obesity, the sympathetic nervous system, and essential hypertension. , 1992, Hypertension.

[64]  F. Abboud,et al.  Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. , 1989, Journal of applied physiology.

[65]  M. Kaste,et al.  Snoring as a risk factor for sleep-related brain infarction. , 1989, Stroke.

[66]  J Sellgren,et al.  Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[67]  K. H. Wesseling,et al.  The Measurement of Continuous Finger Arterial Pressure Noninvasively in Stationary Subjects , 1986 .

[68]  ColinE. Sullivan,et al.  REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES , 1981, The Lancet.